A renewable cell source for cancer immunotherapy could make off-the-shelf treatments possible

In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help drive the body's response against pathogens, and they hold strong promise as the basis for immunotherapies against cancer and other diseases.